Connection

Michael Lilly to Antibodies, Bispecific

Back to Details
This is a "connection" page, showing publications Michael Lilly has written about Antibodies, Bispecific.
Michael Lilly
Connection Strength
0.599
Antibodies, Bispecific
  1. Development of cell-penetrating bispecific antibodies targeting the N-terminal domain of androgen receptor for prostate cancer therapy. Protein Eng Des Sel. 2017 12 01; 30(12):785-793.
    View in: PubMed
    Score: 0.599
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.